Abstract
Objective: As a brain-specific microRNA, the mechanism of miR-124 in depression has not been clarified so far. The present study aimed to explore the role of miR-124 in depression and its potential targets.
Methods: The depression model was first replicated by the chronic unpredictable mild stress (CUMS) method. miR-124 antagomir was injected into the hippocampus of CUMS rats. Sucrose preference test (SPT), open-field test (OFT), elevated-plus maze (EPM), and forced swimming test (FST) were used to analyze the depression-like behavior. The content of norepinephrine (NE), dopamine (DA) and 5-hydroxytryptamine (5-HT) in the hypothalamus was analyzed by ELISA. qRT-PCR and western blot assay were used for functional analysis.
Results: miR-124 expression was up-regulated in the hippocampus of CUMS -induced depression model rats, while CREB1 and BDNF were down-regulated. Administration of miR-124 antagomir in the hippocampus inhibited miR-124 expression in the hippocampus of CUMS rats. Additionally, SPT, OFT, EPM, and FST also showed that miR-124 antagomir can reduce the depression-like behavior of CUMS rats. Furthermore, miR-124 antagomir injection increased the levels of NE, DA and 5-HT in the hypothalamus of CUMS rats. Moreover, miR-124 antagomir injection increased the expression of cyclic AMP-responsive element-binding protein1 (CREB1) and brain-derived neurotrophic factor (BDNF) in the hippocampus. Using the dual-luciferase reporter assay, it was confirmed that miR-124 directly targets 3'UTR of CREB1 and BDNF genes.
Conclusion: Knockdown of miR-124 can improve depression-like behavior in CUMS-induced depressive rats, which may be related at least in part to the up-regulation of CREB1 and BDNF expression in the hippocampus.
Keywords: miR-124, chronic unpredictable mild stress, depression, cyclic AMP-responsive element binding protein1, brainderived neurotrophic factor.
[http://dx.doi.org/10.1111/apt.15325] [PMID: 31157418]
[http://dx.doi.org/10.1097/JCP.0b013e3182228619] [PMID: 21694617]
[http://dx.doi.org/10.1016/j.pnpbp.2018.03.009] [PMID: 29535036]
[http://dx.doi.org/10.1146/annurev-neuro-080317-061822] [PMID: 29618285]
[http://dx.doi.org/10.1007/s10571-019-00684-6] [PMID: 31089834]
[http://dx.doi.org/10.1093/brain/awx366] [PMID: 29408968]
[http://dx.doi.org/10.1016/j.yexcr.2008.06.002] [PMID: 18619591]
[http://dx.doi.org/10.1007/s11064-019-02849-7] [PMID: 31372925]
[http://dx.doi.org/10.1038/nn.2294] [PMID: 19287386]
[PMID: 23947143]
[http://dx.doi.org/10.1016/j.psyneuen.2014.04.009] [PMID: 24882160]
[http://dx.doi.org/10.1016/j.jpsychires.2016.03.015] [PMID: 27078210]
[http://dx.doi.org/10.3389/fnmol.2018.00251] [PMID: 30127715]
[http://dx.doi.org/10.1016/j.yexcr.2018.03.042] [PMID: 29614311]
[http://dx.doi.org/10.1016/j.jad.2015.02.022] [PMID: 25779937]
[http://dx.doi.org/10.1007/s12035-018-1205-7] [PMID: 30003515]
[http://dx.doi.org/10.1371/journal.pone.0192434] [PMID: 29420593]
[http://dx.doi.org/10.1016/j.jep.2015.04.053] [PMID: 25957811]
[http://dx.doi.org/10.1016/j.jad.2017.11.090] [PMID: 29689690]
[http://dx.doi.org/10.4103/1673-5374.232478] [PMID: 29863014]
[http://dx.doi.org/10.1371/journal.pone.0170994] [PMID: 28225778]
[http://dx.doi.org/10.1111/j.1601-183X.2011.00681.x] [PMID: 21272243]
[http://dx.doi.org/10.1017/S1461145709000248] [PMID: 19341512]
[http://dx.doi.org/10.1016/j.brainres.2005.01.007] [PMID: 15777771]
[http://dx.doi.org/10.1371/journal.pone.0063648] [PMID: 23704927]
[http://dx.doi.org/10.1093/hmg/ddn201] [PMID: 18632683]
[http://dx.doi.org/10.1080/15384101.2018.1556060] [PMID: 30589396]
[http://dx.doi.org/10.1017/erm.2016.3] [PMID: 26996991]
[http://dx.doi.org/10.5582/bst.2016.01127] [PMID: 27545218]
[http://dx.doi.org/10.1016/j.neuroscience.2015.04.061] [PMID: 25943483]